Search Results

Biotech fundraising has undergone a subtle yet significant shift. no longer something that comes up late in the process. 👉 It has become an early signal of whether a biotech or heavier legal Attila Foris 5 days ago The Hidden Operating Cadence That’s Actually Driving Your Biotech But here’s the uncomfortable truth: 👉 Your biotech is already running on an operating cadence you didn GPCR News Dec 18, 2025 Scientific Isolation: The Real Reason Early Biotechs Lose Traction The Quiet Drift

He is Chief Scientific Officer and co-founder of InterAx Biotech, where he specializes in the development Aurélien Rizk on the web InterAx Biotech Paul Scherrer Institut The Org LinkedIn Google Scholar Dr. Academia to Biotech: Strategic Planning and Interdisciplinary Approach Yamina Berchiche and Aurelien Rizk discussed the differences between academia and the biotech industry, with Aurelien Rizk sharing his experiences transitioning from academia into the biotech sector.

Biotech founder Ajay Yekkirala shares how AI, GPCRs, and bold questions are driving next-gen pain therapeutics Ajay Yekkirala is a GPCR pharmacologist, biotech entrepreneur, and co-founder of Superluminal Medicines is the heart of scientific innovation Who Should Listen PhD students and postdocs exploring biotech careers GPCR scientists interested in translational innovation Biotech investors and strategic leaders seeking Ajay Yekkirala is a molecular pharmacologist, biotech founder, and scientist whose career has been defined

Building Z7 Biotech – The unexpected journey into biotech entrepreneurship, providing GPCR profiling services to pharma and biotech companies. In 2021 he co-founded Z7 Biotech, developing and providing innovative GPCR drug screening and precision Dmitry Veprintsev on the web LinkedIn Veprintsev Lab Z7 Biotech University of Nottingham Enjoying the It takes <60 seconds and makes a big difference. ★ Review on Apple Podcasts ★ Rate on Spotify ✉️ Send

Join GPCR Happy Hour to connect with scientists across academia, biotech, and pharma - a free networking Cross-sector : Academia, biotech, pharma, CROs all in one room. and Past Happy Hours GPCR Happy Hour – Boston, Sept 2025 Every September, Boston welcomes the global biotech

GPCR Podcast ➚ Articles from the Ecosystem ➚ The One Reason Why Biotech Startups Fail More Often Than They Should Why Biotech Fundraising Fails Due to Intellectual Property Gaps The Hidden Operating Cadence That’s Actually Driving Your Biotech GPCR Binding Affinity Experiments: Interpreting Data With Confidence researchers at every career stage 🚀 Don’t just keep up — lead the way. 🔒 Grandfather Guarantee, your rate

⚠️ Next year’s rate increase is coming. Join today and keep the current price permanently. As a media partner, you'll gain trusted access to an engaged audience of academic researchers, biotech partner, you'll be featured across our nonprofit platform, trusted by thousands of GPCR scientists and biotech ✓ Individual pages for each product or service ✓ Educate researchers and showcase technical value ✓ Social Media Promotion ✓ Engaging posts about your organization ✓ Targeted to GPCR researchers and biotech

Stalled Pipeline Progression ❌ Uncertainty in GPCR Investments Advisory Focus Areas Expert support for Biotech innovators, VC investors and CRO partners Biotech Pipeline Acceleration For Biotech Leaders & Scientists Position: Showcase your specialized GPCR expertise to stand out from competitors and attract high-value biotech I integrate seamlessly with biotech, VC, and CRO teams as a trusted, objective partner. With over two decades dedicated to GPCR pharmacology across biotech, academia, and the non-profit sector

I developed G.CLIPS biotech's innovative technology as a synthesis of the different knowledge, experiences Before founding G.CLIPS biotech in June 2020. GPCR Ecosystem G.CLIPS Biotech on the web Website LinkedIn Enjoying the Dr. GPCR Podcast? It takes <60 seconds and makes a big difference. ★ Review on Apple Podcasts ★ Rate on Spotify ✉️ Send

the University in Graz in Austria, Maria worked several years at Novo Nordisk before joining InterAx Biotech Maria Waldhoer on the web LinkedIn InterAx Biotech Pubmed Dr. GPCR Ecosystem Enjoying the Dr. It takes <60 seconds and makes a big difference. ★ Review on Apple Podcasts ★ Rate on Spotify ✉️ Send

GPCR Retreat — an immersive event uniting scientists, biotech leaders, and innovators in GPCR research

How academia and biotech collaborate to scale GPCR tools—covering fluorescence assays, GPCR internalization GPCR Podcast , leaders from academia and biotech unpack what effective collaboration really looks like outperform antibodies for studying receptor localization and trafficking What changes when academia and biotech Maria Majellaro is the Chief Scientific Officer and co-founder of Celtarys Research , a biotech spin-off It takes <60 seconds and makes a big difference. ★ Review on Apple Podcasts ★ Rate on Spotify ✉️ Send

After switching to biotech, Murat has built cell imaging software and lab robots to accelerate cancer He has co-founded consultancy and biotech companies Svarlight and Antiverse. It takes <60 seconds and makes a big difference. ★ Review on Apple Podcasts ★ Rate on Spotify ✉️ Send

Fast-track your biotech investments with VC Insights. Home About Services News Get in Touch Welcome VC Insights Fast Track Your Next Biotech Bet Get decision-grade talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution across biotech

GPCR was created to break down barriers across academia, biotech, pharma, and CROs—so knowledge, tools field , including: Academic researchers (PI, postdoc, student) Industry scientists and R&D leaders Biotech

talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution across biotech

GPCR to expand fluorescent ligand tools for GPCR drug discovery, connecting biotech startups and scientists

Frequently asked questions University Vault Premium Pricing GPCR Masterclass YC-Biotech YC-VC YC-CRO

CSO of Celtarys Research, shares the story behind the company’s journey from academic curiosity to biotech When the time came to decide whether to leave the lab and lead Celtarys into biotech, she took the leap Like many scientists-turned-entrepreneurs, Maria faced the challenge of learning the business side of biotech That changed with support from Galicia’s robust biotech network, and the company quickly defined its It takes <60 seconds and makes a big difference. ★ Review on Apple Podcasts ★ Rate on Spotify ✉️ Send

Biotech strategy moves from Catalio Capital Management . And your voice in our survey.

GPCR Ecosystem, with the goal is to bring together GPCR scientists, biotech, and pharma leaders as well It takes <60 seconds and makes a big difference. ★ Review on Apple Podcasts ★ Rate on Spotify ✉️ Send

https://www.ecosystem.drgpcr.com/gpcr-university #GPCR #DrGPCR #pharmacology #drugdiscovery #receptors #biotech

https://www.ecosystem.drgpcr.com/gpcr-university-pricing #GPCR #DrGPCR #DrugDiscovery #Pharmacology #Biotech

They collaborate deeply with medicinal chemists, pharmacologists, and biotech partners to create workflows

Session: ⚠️ Today, Oct 30 | 12–1 PM EST #GPCR #DrGPCR #Pharmacology #DrugDiscovery #CareerDevelopment #Biotech

want to support academic labs with the same high-quality tools, courses, and insights used by leading biotech your team receives Renewal options 👉 Everything is explained here *This link takes you to a dedicated page

More broadly, I hope to be a critical contributor to a growing Canadian biotech sector in both scientific It takes <60 seconds and makes a big difference. ★ Review on Apple Podcasts ★ Rate on Spotify ✉️ Send

Inoviem scientific in Nov. 2011 by myself we have been regularly working with GPCRs for our pharma and biotech It takes <60 seconds and makes a big difference. ★ Review on Apple Podcasts ★ Rate on Spotify ✉️ Send

Annette worked in industry, academia and her entrepreneurial side led her to three companies, Cue Biotech It takes <60 seconds and makes a big difference. ★ Review on Apple Podcasts ★ Rate on Spotify ✉️ Send

Jens Carlsson started his journey aiming to be a biotech engineer.